CDK4 and mantle cell lymphoma: These PROTACs also targeted Ikaros (IKZF1) and Aiolos (IKZF3) and showed enhanced antiproliferative effects in mantle cell lymphoma (MCL) cell lines when both CDK4/6 and IKZF1/3 were degraded simultaneously.